OKUR - Onkure Therapeutics, Inc.

Insider activity in OKUR over the last quarter tilts toward selling: insiders offloaded a net 389 shares worth roughly $1K.

Classified under Biotechnology (Health Care sector), OKUR's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Manke Isaac	20.6K	-	-
CFO	Leverone Jason A.	18.5K	$55.0K	-
Dir	Mathers Edward T	15.3K	-	-
CEO	Saccomano Nicholas A	11.2K	$33.2K	-

Buys and sells only

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Sep 21, 2026	Saccomano Nicholas A	President and CEO	Sell	87	$2.97	$258.76	-0.8%	-	-
Sep 21, 2026	Leverone Jason A.	Chief Financial Officer	Sell	302	$2.97	$898.21	-1.6%	-	-
Jun 22, 2026	Saccomano Nicholas A	President and CEO	Sell	86	$4.40	$378.08	-0.8%	-31.1%	-
Jun 22, 2026	Leverone Jason A.	Chief Financial Officer	Sell	303	$4.40	$1,332.08	-1.6%	-31.1%	-
Mar 23, 2026	Leverone Jason A.	Chief Financial Officer	Sell	301	$4.16	$1,251.11	-1.8%	+11.6%	-
Mar 23, 2026	Saccomano Nicholas A	President and CEO	Sell	86	$4.16	$357.46	-1.2%	+11.6%	-
Dec 22, 2025	Leverone Jason A.	Chief Financial Officer	Sell	302	$2.97	$896.25	-1.8%	+34.5%	-
Dec 22, 2025	Saccomano Nicholas A	President and CEO	Sell	87	$2.97	$258.19	-1.2%	+34.5%	-
Sep 22, 2025	Leverone Jason A.	Chief Financial Officer	Sell	303	$2.62	$794.92	-2.3%	+13.4%	+18.8%
Sep 22, 2025	Saccomano Nicholas A	President and CEO	Sell	88	$2.62	$230.87	-2.4%	+13.4%	+18.8%